SCHAFFER DAVID 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | SCHAFFER DAVID | 901,215 2.800% | -1,098,785 (-54.94%) | Filing |
| 2021-02-12 9:30 pm Purchase | 2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | SCHAFFER DAVID | 2,000,000 7.500% | 2,000,000 (New Position) | Filing |